Banque Pictet & Cie’s iShares Biotechnology ETF IBB Stock Holding History

Banque Pictet & Cie’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-270,000	Closed	-$33.2M	–	399
2015 Q2	$33.2M	Hold	270,000	–	–	2.65%	6
2015 Q1	$30.9M	Buy	270,000 +135,000	+100%	+$14.9M	0.81%	28
2014 Q4	$13.7M	Hold	135,000	–	–	0.36%	61
2014 Q3	$12.3M	Hold	135,000	–	–	0.32%	67
2014 Q2	$11.6M	Hold	135,000	–	–	0.29%	69
2014 Q1	$10.6M	Buy	+135,000	New	+$11.2M	0.29%	63

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Banque Pictet & Cie's IBB Position: Q2 2025 in Review

Banque Pictet & Cie sold out of iShares Biotechnology ETF (IBB) in Q2 2025, closing a stake of 8,690 shares — an estimated $1.11M sold.

Banque Pictet & Cie first reported a position in IBB in Q4 2013 and held it in 45 quarters. The position peaked at $17.9M in Q4 2015. 797 funds tracked by Wall St. Rank hold IBB as of Q2 2025.

Banque Pictet & Cie reported no remaining iShares Biotechnology ETF position as of Q2 2025 after selling out during the quarter.
Banque Pictet & Cie sold 8,690 iShares Biotechnology ETF shares in Q2 2025, an estimated $1.11M.
Banque Pictet & Cie first reported a position in iShares Biotechnology ETF in Q4 2013 and held it in 45 quarters.
Banque Pictet & Cie's iShares Biotechnology ETF position peaked at $17.9M in Q4 2015.
797 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2025.

Based on Banque Pictet & Cie's 13F filing for Q2 2025, filed 16 Jul 2025.